“To Determine the Frequency of Biochemical Adverse Effects in Patients on Meglumine Antimoniate Treatment for Cutaneous Leishmaniasis”. Medical Forum Monthly, vol. 30, no. 9, May 2024, https://medicalforummonthly.com/index.php/mfm/article/view/3872.